v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04381962 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : May 8, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : May 8, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Lucy Cureton, atomic2@ndorms.ox.ac.uk (PI email not reported) |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-05-11 |
Recruitment status
Last imported at : May 8, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
inclusion criteria: - male or female, aged at least 18 years - assessed by the attending clinical team as appropriate for initial ambulatory (outpatient) management - a clinical diagnosis of highly-probable covid-19 infection (diagnosis by the attending clinical team) - no medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial - able to understand written english (for the information and consent process) and be able to give informed consent |
Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
- known hypersensitivity to any macrolide including azithromycin, ketolide antibiotic, or the excipients including an allergy to soya or peanuts. - known fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase-insufficiency - currently on a macrolide antibiotic (clarithromycin, azithromycin, erythromycin, telithromycin, spiramycin) - on any ssri (selective serotonin reuptake inhibitor) - elevated cardiac troponin at initial assessment suggestive of significant myocarditis (if clinically the clinical team have felt it appropriate to check the patient's troponin levels) - evidence of qtc prolongation: qtc>480ms - significant electrolyte disturbance (e.g. hypokalaemia k+<3.5 mmol/l) - clinically relevant bradycardia (p<50 bpm), non-sustained ventricular tachycardia or unstable severe cardiac insufficiency - currently on hydroxychloroquine or chloroquine |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
University of Oxford |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
19 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
United Kingdom |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Mild disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
1: Mild disease at enrollment |
Total sample size
Last imported at : May 8, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
298 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Proportion progressing to respiratory failure or death (all clinically-diagnosed participants) |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 165, "treatment_name": "Azithromycin", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |